| Q33783932 | Benign liver lesions: differentiation by magnetic resonance |
| Q37278614 | Biodistribution of newly synthesized PHEA-based polymer-coated SPION in Sprague Dawley rats as magnetic resonance contrast agent |
| Q59125953 | Biosafety evaluation of Janus Fe 3 O 4 -TiO 2 nanoparticles in Sprague Dawley rats after intravenous injection |
| Q77979378 | Contrast-enhanced MR imaging of two superparamagnetic RES-contrast agents: functional assessment of experimental radiation-induced liver injury |
| Q33933435 | Delivery of diagnostic agents for magnetic resonance imaging |
| Q73912587 | Detection of focal hepatic lesions: comparison of unenhanced and SHU 555 A-enhanced MR imaging versus biphasic helical CTAP |
| Q77361360 | Diagnostic efficacy and safety of MRI of the liver with superparamagnetic iron oxide particles (SH U 555 A) |
| Q74631094 | Evaluation of the time window for Resovist-enhanced T2-weighted MRI of the liver |
| Q97692905 | Ex vivo magnetic particle imaging of vascular inflammation in abdominal aortic aneurysm in a murine model |
| Q33549945 | Functional investigations on human mesenchymal stem cells exposed to magnetic fields and labeled with clinically approved iron nanoparticles |
| Q85623526 | Imaging of focal nodular hyperplastic-like nodules in alcoholic liver cirrhosis patients using gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid magnetic resonance imaging |
| Q90730182 | In Vivo Experimental Study of an Endoscopic Ultrasound Multifunctional Radiofrequency Ablation Probe |
| Q32081106 | Liver-specific MR imaging contrast agents |
| Q35083377 | MR imaging of liver tumors |
| Q77409279 | MR imaging of the liver and spleen: a comparison of the effects on signal intensity of two superparamagnetic iron oxide agents |
| Q45155004 | MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents |
| Q39017070 | Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy |
| Q41721368 | Magnetic resonance imaging of focal and diffuse hepatic disease |
| Q34391672 | Magnetic resonance imaging of the liver: New imaging strategies for evaluating focal liver lesions |
| Q98463504 | Magnetic resonance imaging of umbilical cord stem cells labeled with superparamagnetic iron oxide nanoparticles: effects of labelling and transplantation parameters |
| Q36204115 | Molecular imaging of tumor invasion and metastases: the role of MRI. |
| Q37222159 | Multimodality nanotracers for cardiovascular applications. |
| Q36832322 | Surgical therapy for colorectal metastases to the liver |
| Q48146534 | Ten Things You Might Not Know about Iron Oxide Nanoparticles |
| Q42084161 | The effects of iron oxide incorporation on the chondrogenic potential of three human cell types |
| Q50474848 | USPIO-loaded red blood cells as a biomimetic MR contrast agent: a relaxometric study. |